Cow's milk formula each day may keep milk allergy away

Aikaterini Anagnostou; Julia Upton; Anna Nowak-Wegrzyn

doi:10.1016/j.anai.2022.11.012

Cow's milk formula each day may keep milk allergy away

Aikaterini Anagnostou, Julia Upton, Anna Nowak-Wegrzyn

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	151-152
Number of pages	2
Journal	Annals of Allergy, Asthma and Immunology
Volume	130
Issue number	2
DOIs	https://doi.org/10.1016/j.anai.2022.11.012
State	Published - Feb 2023
Externally published	Yes

Access to Document

10.1016/j.anai.2022.11.012

Cite this

@article{92ae07a4421f48e18a5ae58fa3c75585,

title = "Cow's milk formula each day may keep milk allergy away",

author = "Aikaterini Anagnostou and Julia Upton and Anna Nowak-Wegrzyn",

note = "Funding Information: Disclosures: Dr Anagnostou reports receiving grants from Aimmune Therapeutics during the conduct of the study; personal fees from DBV Technologies; grants and personal fees from FARE; and personal fees from ALK outside the submitted work. Dr Upton reports receiving research support and grants from Novartis, Regeneron, ALK, DBV, CIHR, and fees from AstraZeneca, Pfizer, ALK Abello, Bausch Health, Kaleo, Food Allergy Canada, all outside the submitted work. Dr Nowak-Wegrzyn reports receiving research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermofisher; royalties from UpToDate; serving as an Associate Editor for the Annals of Allergy, Asthma, and Immunology, as chair of the ABAI Board of Directors, as director of the AAAAI Board, and is the Chair of the Medical Advisory Board of the International FPIES Association. Funding Information: Disclosures: Dr Anagnostou reports receiving grants from Aimmune Therapeutics during the conduct of the study; personal fees from DBV Technologies; grants and personal fees from FARE; and personal fees from ALK outside the submitted work. Dr Upton reports receiving research support and grants from Novartis, Regeneron, ALK, DBV, CIHR, and fees from AstraZeneca, Pfizer, ALK Abello, Bausch Health, Kaleo, Food Allergy Canada, all outside the submitted work. Dr Nowak-Wegrzyn reports receiving research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermofisher; royalties from UpToDate; serving as an Associate Editor for the Annals of Allergy, Asthma, and Immunology, as chair of the ABAI Board of Directors, as director of the AAAAI Board, and is the Chair of the Medical Advisory Board of the International FPIES Association. Funding: The authors have no funding sources to report.",

year = "2023",

month = feb,

doi = "10.1016/j.anai.2022.11.012",

language = "English",

volume = "130",

pages = "151--152",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "2",

}

TY - JOUR

T1 - Cow's milk formula each day may keep milk allergy away

AU - Anagnostou, Aikaterini

AU - Upton, Julia

AU - Nowak-Wegrzyn, Anna

N1 - Funding Information: Disclosures: Dr Anagnostou reports receiving grants from Aimmune Therapeutics during the conduct of the study; personal fees from DBV Technologies; grants and personal fees from FARE; and personal fees from ALK outside the submitted work. Dr Upton reports receiving research support and grants from Novartis, Regeneron, ALK, DBV, CIHR, and fees from AstraZeneca, Pfizer, ALK Abello, Bausch Health, Kaleo, Food Allergy Canada, all outside the submitted work. Dr Nowak-Wegrzyn reports receiving research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermofisher; royalties from UpToDate; serving as an Associate Editor for the Annals of Allergy, Asthma, and Immunology, as chair of the ABAI Board of Directors, as director of the AAAAI Board, and is the Chair of the Medical Advisory Board of the International FPIES Association. Funding Information: Disclosures: Dr Anagnostou reports receiving grants from Aimmune Therapeutics during the conduct of the study; personal fees from DBV Technologies; grants and personal fees from FARE; and personal fees from ALK outside the submitted work. Dr Upton reports receiving research support and grants from Novartis, Regeneron, ALK, DBV, CIHR, and fees from AstraZeneca, Pfizer, ALK Abello, Bausch Health, Kaleo, Food Allergy Canada, all outside the submitted work. Dr Nowak-Wegrzyn reports receiving research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermofisher; royalties from UpToDate; serving as an Associate Editor for the Annals of Allergy, Asthma, and Immunology, as chair of the ABAI Board of Directors, as director of the AAAAI Board, and is the Chair of the Medical Advisory Board of the International FPIES Association. Funding: The authors have no funding sources to report.

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85146623686&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2022.11.012

DO - 10.1016/j.anai.2022.11.012

M3 - Editorial

AN - SCOPUS:85146623686

SN - 1081-1206

VL - 130

SP - 151

EP - 152

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 2

ER -